07 Jan 2001

Finalgon®; -extra (Finalgon® Creme) - Deutschland

Updated: 07 Jan 2001

Finalgon®; -extra stark Salbe

Muskel-, Gelenk- u. Nervenschmerzen rheumatischer Art. Muskelkater, Sportverletzungen.

Finalgon®; -extra Description, Presentation and Dosage

Finalgon®; -extra Description

Finalgon®; -extra Drug Class Description

Kombinationen

Finalgon®; -extra Drug Description

1 g enth.: Nonivamid 1,7 mg, Nicoboxil 10,8 mg.

Finalgon®; -extra Generic Name

Finalgon® Creme

Finalgon®; -extra Presentation

Finalgon®; -extra Presentation

Finalgon®; -extra stark Salbe

Finalgon®; -extra Manufacturer

Boehringer Ingelheim

Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Finalgon®; -extra Dosage

Finalgon®; -extra Adult Dosage

Cetomacrogol, Cetylstearylalkohol, Cetylstearylalkohol emulg. Aromastoffe, Decyloleat, Paraffin, Sorbinsäure, Stearinsäure.

Finalgon®; -extra Child Dosage


Finalgon® extra stark Salbe
Zus.: 1 g enth.: Nonivamid 4 mg, Nicoboxil 25 mg.
Weit. Bestandteile: Citronellöl, Diisopropyladipat, hochdisperses Siliciumdioxid, Sorbinsäure, weißes Vaselin.

Finalgon®; -extra Precautions, Reactions and Contraindications

Finalgon®; -extra Special Precautions

Related Drugs - Allergy/Clinical Immunology

Back to top